Tenax Therapeutics, Inc (TENX) insider trading
Every open-market stock purchase and sale by Tenax Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- ADAR1 Capital Management LLC (10% owner) and 3 others bought $6.4M in the last 90 days, growing their stake 18%.
Last 12 months: insiders bought $6.6M (13 buys) and sold $0 (0 sales). Last close $1.76 on Oct 22, 2026.
Recent TENX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 21, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $551K |
| Oct 20, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $406K |
| Oct 19, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $507K |
| Sep 16, 2026 | Declan Doogan (Insider) | Bought | $102K |
| Sep 15, 2026 | Christopher Thomas Giordano (CEO) | Bought | $8.8K |
| Sep 11, 2026 | Christopher Thomas Giordano (CEO) | Bought | $11.3K |
| Sep 11, 2026 | Thomas R Staab II (CFO) | Bought | $11K |
| Sep 3, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $1.6M |
| Sep 2, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $338K |
| Sep 1, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $322K |
| Aug 31, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $723K |
| Aug 24, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $188K |
| Aug 21, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $1.3M |
| Aug 20, 2026 | ADAR1 Capital Management LLC (10% owner) | Bought | $360K |
| Jul 13, 2026 | Christopher Thomas Giordano (CEO) | Bought (not open market) | $50.5K |
| Jul 13, 2026 | Christopher Thomas Giordano (CEO) | Bought (not open market) | $777 |
| Jul 13, 2026 | Christopher Thomas Giordano (CEO) | Bought (not open market) | — |
| Jul 13, 2026 | Christopher Thomas Giordano (CEO) | Bought (not open market) | — |
| May 11, 2026 | Thomas R Staab II (CFO) | Bought (not open market) | — |
| May 11, 2026 | Thomas R Staab II (CFO) | Bought (not open market) | — |
| Jan 30, 2026 | Thomas McGauley (CFO) | Bought (not open market) | — |
| Jan 9, 2026 | Michael H. Davidson (Director) | Bought (not open market) | — |
| Jan 9, 2026 | Declan Doogan (Director) | Bought (not open market) | — |
| Jan 9, 2026 | Gerald T Proehl (Director) | Bought (not open market) | — |
| Jan 9, 2026 | Stuart Rich (C-suite exec) | Bought (not open market) | — |
Who's trading TENX
- ADAR1 Capital Management LLC, 10% owner: bought $6.3M (10 buys), last Oct 21, 2026
- Declan Doogan, Insider: bought $102K (1 buy), last Sep 16, 2026
- Christopher Thomas Giordano, CEO: bought $40.1K (5 buys), last Sep 15, 2026
- Thomas R Staab II, CFO: bought $11K (1 buy), last Sep 11, 2026
- Thomas McGauley, CFO: bought $58.2K (3 buys), last Jan 30, 2026
- Michael H. Davidson, Insider: other filings, last Jan 9, 2026
- Robyn Hunter, Insider: other filings, last Jan 9, 2026
- Gerald T Proehl, Insider: other filings, last Jan 9, 2026
- Stuart Rich, C-suite exec: bought $96.4K (5 buys), last Jan 9, 2026
- June Sherie Almenoff, Director: bought $29.9K (4 buys), last Jan 9, 2026
Get free alerts when an insider at Tenax Therapeutics, Inc files a new trade →